Trichomonas Vaginalis By Aptima – Test Update

This will take effect June 9, 2014

Overview and Clinical Utility:

PathGroup is pleased to announce the immediate availability of the FDA-approved APTIMA Trichomonas vaginalis detection assay by Hologic. Trichomonas vaginalis is the most common curable sexually transmitted disease (STD) agent in the United States, with an estimated 7.4 million new cases occurring annually. Infections in women cause vaginitis, urethritis, and cervicitis. Discharge and small hemorrhagic lesions may be present in the genitourinary tract.

Click Here to read more.